Satnic-60 Injection contains Artesunate IP, an effective antimalarial medication recommended by the WHO for severe malaria cases. Administered intravenously, it rapidly clears Plasmodium parasites from the bloodstream, reducing mortality rates. Satnic-60 Injection is crucial in regions with multidrug-resistant malaria strains, ensuring swift treatment and recovery. Its formulation is tailored for emergency situations, providing essential support in combating severe malaria infections where prompt intervention is critical for patient survival.Available in PCD Franchise for injectable range and third party manufacturing.